Overcoming HCV 2020 

Friday, October 2nd, 2020 at 12:00pm EDT (Zoom)

Speaker:

Mark Sulkowski MD
Mark S. Sulkowski, MD
Johns Hopkins Hospital
Director, Viral Hepatitis Center
Infectious Disease Specialist
Professor of Medicine
Baltimore, MD
 
  
     
Scoll down to access the program LOG-IN window at the bottom of this page!
 

Target Audience

This activity hasbeen designed to meet the educational needs of physicians, physicianassistants, advanced practice nurses and other health care professionalsinvolved in the care of patients with HIV infection. It is tuition-free andthere are no prerequisites.

 

Learning Objectives

Upon completion of theactivity, participants should be better able to:

  • Describe the changing demographics of and risk factors for CHC
  • Improve the rate of testing and diagnosis of patients with CHC
  • Link patients with diagnosed CHC to timey and appropriate HCV therapy
  • Provide optimal, individualized HCV therapy to patients with CHC that results in improved outcomes

Joint Accreditation Statement:

Insupport of improving patient care, this activity has been planned andimplemented by the Postgraduate Institute for Medicine and ViralEd, Inc.Postgraduate Institute for Medicine is jointly accredited by the AccreditationCouncil for Continuing Medical Education (ACCME), the Accreditation Council forPharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC),to provide continuing education for the healthcare team.

ThePostgraduate Institute for Medicine designates this live activity for a maximumof 1.0 AMA PRA Category 1 Credit(s)™. Physiciansshould claim only the credit commensurate with the extent of theirparticipation in the activity.

A statement of credit will beissued only upon receipt of a completed activity evaluation form and will be emailedto you.


Disclosure of Conflicts ofInterest

PostgraduateInstitute for Medicine (PIM) requires instructors, planners, managers and otherindividuals who are in a position to control the content of this activity todisclose any real or apparent conflict of interest (COI) they may have asrelated to the content of this activity. All identified COI are thoroughlyvetted and resolved according to PIM policy. 
PIM is committed to providing its learners with high quality CMEactivities and related materials that promote improvements or quality in healthcareand not a specific proprietary business interest of a commercial interest.


The faculty reported the following financialrelationships or relationships they or their spouse/life partner have withcommercial interests related to the content of this continuing educationactivity:

 

Mark Sulkowski, MD, 
  •  Consutant Fees: Gilead, BMS, Janssen, Bayer, Salix, AbbVie
  • Fees for Non-CME/CE Services: Gilead, BMS, Janssen, Bayer, Salix, AbbVie

ThePIM and ViralEd planners and managers have nothing to disclose.

 

Disclosure of Unlabeled Use

This educationalactivity may contain discussion of published and/or investigational uses ofagents that are not indicated by the FDA. The planners of this activity do notrecommend the use of any agent outside of the labeled indications. 

 

The opinions expressedin the educational activity are those of the faculty and do not necessarilyrepresent the views of the planners. Please refer to the official prescribing information for each productfor discussion of approved indications, contraindications, and warnings.


Disclaimer

Participants have animplied responsibility to use the newly acquired information to enhance patientoutcomes and their own professional development. The information presented inthis activity is not meant to serve as a guideline for patient management. Anyprocedures, medications, or other courses of diagnosis or treatment discussedor suggested in this activity should not be used by clinicians withoutevaluation of their patient’s conditions and possible contraindications and/ordangers in use, review of any applicable manufacturer’s product information,and comparison with recommendations of other authorities.

 

 

FILL OUT THE FORM BELOW TO JOIN OUR PROGRAM

 

Overcoming Obstacles in HCV - 10/2/20
Your name *
Email address *
Degree/Profession *
Country *
How many participants are watching using your internet connection? *
 
* Required